Duchesne G, Crow J, Ashley S, Brada M, Horwich A
Department of Radiotherapy, Royal Marsden Hospital, Surrey, UK.
Br J Cancer. 1989 Aug;60(2):227-30. doi: 10.1038/bjc.1989.257.
The patterns of early and late relapses (those occurring later than 3 years after diagnosis) in 432 patients achieving complete remission after treatment for stage I and II Hodgkin's disease at the Royal Marsden Hospital between 1964 and 1983 were studied to identify factors predicting for late relapse. The incidence of early relapse has fallen progressively in recent treatment eras as staging procedures and management have improved but in contrast there has been no decrease in the risk of late relapse. The incidence of late relapse was greater in patients treated with radiotherapy rather than combined modality therapy (P less than 0.05). However, patients who were clinically staged and treated with combined modality therapy retained as high a risk of relapse between 3 and 6 years as in years 2 and 3. The risk of late relapse was also greater in patients with stage II disease and in those without B symptoms at presentation. Patients falling into the higher risk categories for late relapse require continued close follow-up beyond 3 years to monitor for possible relapse.
对1964年至1983年间在皇家马斯登医院接受I期和II期霍奇金病治疗后实现完全缓解的432例患者的早期和晚期复发(诊断后3年以后发生的复发)模式进行了研究,以确定预测晚期复发的因素。随着分期程序和治疗方法的改进,早期复发的发生率在最近的治疗时代逐渐下降,但相比之下,晚期复发的风险并未降低。接受放疗而非综合治疗的患者晚期复发的发生率更高(P<0.05)。然而,经临床分期并接受综合治疗的患者在3至6年之间的复发风险与第2年和第3年一样高。II期疾病患者以及初诊时无B症状的患者晚期复发的风险也更高。属于晚期复发高风险类别的患者在3年后需要继续密切随访,以监测可能的复发情况。